← Back to Clinical Trials
Recruiting NCT05868902

NCT05868902 A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05868902
Status Recruiting
Phase
Sponsor Genetesis Inc.
Condition Coronary; Ischemic
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2023-08-28
Primary Completion 2025-06-01

Trial Parameters

Condition Coronary; Ischemic
Sponsor Genetesis Inc.
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 40 Years
Max Age N/A
Start Date 2023-08-28
Completion 2025-06-01
Interventions
CardioFlux Magnetocardiography

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.

Eligibility Criteria

Inclusion Criteria: * Willing to provide informed consent * Male or female, aged 40 and up (inclusive) at the time of enrollment * Clinical suspicion of myocardial ischemia that clinician desired cardiac PET * Completed cardiac PET within 2 weeks prior to study enrollment Exclusion Criteria: * Patients unable to fit into CardioFlux device. * Patients unable to lie supine for 5 minutes. * Patients with implanted ferromagnetic objects above the costal margin of the rib cage (implanted pacemakers, cardioverter/defibrillators, infusion pumps, and/or neuro stimulators). NOTE: Sternotomy wires stents are acceptable * Ongoing atrial fibrillation or atrial flutter * Life expectancy \<1 yrs. due to non-cardiovascular comorbidity

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology